Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis

Vivek Verma1, Valerie K. Shostrom2, Weining Zhen1, Mutian Zhang1, Steve E. Braunstein3, John Holland4, Christopher L. Hallemeier5, Matthew M. Harkenrider6, Adrian Iskhanian7, Salma K. Jabbour8, Albert Attia9, Percy Lee10, Kyle Wang11, Roy H. Decker12, Ronald C. McGarry13, Charles B. Simone14
1Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska
2Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska
3Department of Radiation Oncology, University of California-San Francisco, San Francisco, California
4Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon
5Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
6Department of Radiation Oncology, Loyola University Stritch School of Medicine, Maywood, Illinois
7Department of Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida
8Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey
9Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee
10Department of Radiation Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California
11Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
12Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut
13Department of Radiation Oncology, University of Kentucky, Lexington, Kentucky
14Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland

Tài liệu tham khảo